3rd Quarter - Report

THE PEW CHARITABLE TRUSTS for THE PEW CHARITABLE TRUSTS

Firm
Client
Income
—
Expenses
$480,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Consumer Issues/Safety/Products CSP

Issues related to securing passage of safe checking reform

LobbyistCovered position, as disclosed
CAROLYN BRICKEY Sen. Comm. on Agr., Nut. & Forestry, Sr. Counsel

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Agriculture, Dept of (USDA); SENATE

Budget/Appropriations BUD

H.R. 2112, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2012, issues related to funding food safety at the FDA and issues related to school funding and equipment FY 2012, appropriations and authorization of programs to strengthen nutritious and healthful meals FY 2012, appropriations related to Food Safety Modernization Act

LobbyistCovered position, as disclosed
CAROLYN BRICKEY Sen. Comm. on Agr., Nut. & Forestry, Sr. Counsel
SANDRA ESKIN —

Contacted: Agriculture, Dept of (USDA); SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Bills named: H.R. 2112 (112th)

Food Industry (safety, labeling, etc.) FOO

Issues related to the implementation of the Food Safety Modernization Act Issues related to the Farm Bill, specifically food safety legislation and the authorization of a loan program for school equipment Issues related to FDA guidance 209, the use of antibiotics on the farm Issues related to the development of a fee-based funding proposal for FDA

LobbyistCovered position, as disclosed
CAROLYN BRICKEY Sen. Comm. on Agr., Nut. & Forestry, Sr. Counsel
SANDRA ESKIN —

Contacted: Agriculture, Dept of (USDA); SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.